SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-23-001812
Filing Date
2023-10-12
Accepted
2023-10-12 15:57:43
Documents
15
Period of Report
2023-10-10
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 36169
2 PRESS RELEASE lxrp_ex991.htm EX-99.1 7469
  Complete submission text file 0001640334-23-001812.txt   169247

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20231010.xsd EX-101.SCH 5759
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20231010_lab.xml EX-101.LAB 14064
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20231010_cal.xml EX-101.CAL 924
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20231010_pre.xml EX-101.PRE 8909
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20231010_def.xml EX-101.DEF 2125
9 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 3483
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 231322701
SIC: 2834 Pharmaceutical Preparations